The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence
Posttraumatic stress disorder (PTSD) is a devastating condition, for which there are few pharmacological agents, often with a delayed onset of action and poor efficacy. Trauma-focused psychotherapies are further limited by few trained providers and low patient engagement. This frequently results in...
Main Authors: | Anya Ragnhildstveit, Jeremy Roscoe, Lisa C. Bass, Christopher L. Averill, Chadi G. Abdallah, Lynnette A. Averill |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-03-01
|
Series: | Therapeutic Advances in Psychopharmacology |
Online Access: | https://doi.org/10.1177/20451253231154125 |
Similar Items
-
Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report
by: Anya Ragnhildstveit, et al.
Published: (2023-02-01) -
Topology of brain functional connectivity networks in posttraumatic stress disorder
by: Teddy J. Akiki, et al.
Published: (2018-10-01) -
5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study
by: Anya Ragnhildstveit, et al.
Published: (2023-11-01) -
Salience Network Disruption in U.S. Army Soldiers With Posttraumatic Stress Disorder
by: Chadi G. Abdallah, et al.
Published: (2019-05-01) -
Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder
by: Siyan Fan, et al.
Published: (2020-12-01)